Bio-Reference Laboratories Inc.‘s (BRLI) share price has entered into oversold territory with a stochastic value of 15.2582. The Zacks Consensus Estimate on the company’s earnings for October 2012 increased by 4 cents over the past month to $1.43 per share. Bio-Reference Laboratories Inc. is a Zacks #2 Rank (” Buy”) company.
To read this article on Zacks.com click here.
Zacks Investment Research
